Interviews


Click here to view video
Kingston Resources (ASX:KSN) - gold explorer & developer
Kingston Resources (ASX:KSN) - gold explorer & developer

03 Aug 2020 - Kingston Resources Limited (ASX:KSN) Managing Director Andrew Corbett provides an update on the company's Misima and Livingstone Gold Projects.

Click here to view video
Market Update with Shaw & Partner's Martin Crabb, July 2020
Market Update with Shaw & Partner's Martin Crabb, July 2020

31 July 2020 - Shaw and Partners' Chief Investment Officer Martin Crabb discusses global economic conditions in the US and Europe and assesses how markets are reacting to COVID-19, explaining the implications for the Australian market

Click here to view video
Noxopharm (ASX:NOX) - Converting "cold" cancer tumours to "hot" tumours
Noxopharm (ASX:NOX) - Converting "cold" cancer tumours to "hot" tumours

23 Jul 2020 - Noxopharm Limited (ASX:NOX) Executive Chairman and CEO Dr Graham Kelly discusses important pre-clinical results for the company's programs.

Click here to view video
BluGlass (ASX:BLG) - commercial scaling milestone
BluGlass (ASX:BLG) - commercial scaling milestone

20 Jul 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO Giles Bourne gives an update on the commissioning of the BLG 500 at Silverwater, strategic alliances and product roadmap.

Click here to view video
Recce Pharmaceuticals (ASX:RCE) broad spectrum antibiotic potential
Recce Pharmaceuticals (ASX:RCE) broad spectrum antibiotic potential

15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.

Click here to view video
Renergen (ASX:RLT) Quantifies Prospective Resources at 344 Billion Cubic Feet
Renergen (ASX:RLT) Quantifies Prospective Resources at 344 Billion Cubic Feet

08 Jul 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO Stefano Marani talks about the company's high concentration of helium from Phase 1 drill results at its Virginia Gas Field in the Karoo Basin, South Africa.

Click here to view video
Acorn Capital on investing in resources stocks
Acorn Capital on investing in resources stocks

24 Jun 2020 - Acorn Capital, portfolio manager Rick Squire talks about the energy and resource sectors, some of the funds best ideas and outlook for commodities and energy prices as the world emerges from OCIVD-19 lockdown.

Click here to view video
Immutep (ASX:IMM) global leader in development of LAG 3 Gene immuno-therapies
Immutep (ASX:IMM) global leader in development of LAG 3 Gene immuno-therapies

24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.

Click here to view video
Renergen (ASX:RLT) signs LNG deal with Total South Africa
Renergen (ASX:RLT) signs LNG deal with Total South Africa

23 June 2020 - Renergen Limited (ASX:RLT) Managing Director Stefano Marani talks about the significance of the company's marketing and distribution agreement with Total South Africa for LNG from Phase 1 of its project.

Click here to view video
Andrew Schwartz, Founder of the Qualitas Group
Andrew Schwartz, Founder of the Qualitas Group

22 Jun 2020 - An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.

Click here to view video
5 hacks for harnessing the power of social media in financial services
5 hacks for harnessing the power of social media in financial services

16 June 2020 - Social Tree Global co-founders, Max Hannah and James Saward-Anderson share their top 5 hacks for harnessing the power of social media in financial services.

Click here to view video
Zelira Therapeutics (ASX:ZLD) developing clinically validated medicinal cannabis products
Zelira Therapeutics (ASX:ZLD) developing clinically validated medicinal cannabis products

16 Jun 2020 - Zelira Therapeutics Limited (ASX:ZLD) Managing Director Ex USA, Dr Richard Hopkins talks about the company's pipeline of products in clinical development targeting insomnia, chronic pain and autism, its model for rapid commercialisation, its go-to-market strategy and first revenues from US licensing partners.

Click here to view video
MGM Wireless (ASX:MWR) launching Seniors wearable device in June
MGM Wireless (ASX:MWR) launching Seniors wearable device in June

11 Jun 2020 - MGM Wireless Limited (ASX:MWR) CEO, Mark Fortunatow talks about growth in the company's SPACETALK brand of wearables for kids, new product categories, distribution, and growth in wearables from niche product to mainstream.

Click here to view video
Brickworks (ASX:BKW) strength in diversified holdings
Brickworks (ASX:BKW) strength in diversified holdings

11 Jun 2020 - Brickworks Limited (ASX:BKW) Managing Director, Lindsay Partridge talks the company's expectations for growth in building materials, its property and investment portfolio in light of COVID-19 and how its diversified portfolio is its strength in times of uncertainty.

Click here to view video
Lepidico (ASX:LPD) sustainable lithium chemical from lepidolite
Lepidico (ASX:LPD) sustainable lithium chemical from lepidolite

10 June 2020 - Lepidico Limited (ASX:LPD) Managing Director, Joe Walsh provides an update on the company's plans to transition its Phase 1 Project to development following the recent completion of a Definitive Feasibility Study for the redevelopment of two mines in Namibia and a chemical conversion plant in Abu Dhabi that employs Lepidico's proprietary process technologies.

Click here to view video
First Graphene (ASX:FGR) completes capital raising
First Graphene (ASX:FGR) completes capital raising

09 Jun 2020 - First Graphene Limited (ASX:FGR) Non-Executive Chairman Warwick Grigor talks about graphene-enhanced products, the company's capital raising and its focus on the mining industry.

Click here to view video
Market Update with Shaw & Partner's Martin Crabb, June 2020
Market Update with Shaw & Partner's Martin Crabb, June 2020

05 June 2020 - Shaw and Partners' Chief Investment Officer Martin Crabb analyses volatility in EOFY market conditions, discussing liquidity, dividend income & investment into gold.

Click here to view video
Cyclopharm (ASX:CYC) US FDA progress for Technegas
Cyclopharm (ASX:CYC) US FDA progress for Technegas

03 Jun 2020 - Cyclopharm (ASX:CYC) Managing Director and CEO James McBrayer provides an update on US FDA progress with Technegas, approval in Russia and potential use of Technegas in the diagnosis and management of COVID-19.

Click here to view video
NetLinkz (ASX:NET) - networking specialist
NetLinkz (ASX:NET) - networking specialist

01 Jun 2020 - NetLinkz Limited (ASX:NET) Executive Chairman & CEO James Tsiolis provides an update on the company's suite of networking solutions, the market opportunity and progress with partners.

Click here to view video
OncoSil Medical (ASX:OSL) gets CE approval
OncoSil Medical (ASX:OSL) gets CE approval

01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.

Click here to view video
Hazer Group (ASX:HZR) - hydrogen gas from biogas
Hazer Group (ASX:HZR) - hydrogen gas from biogas

27 May 2020 - Hazer Group Limited (ASX:HZR) Managing Director and CEO Geoff Ward talks about the Hazer process for low emissions hydrogen gas and high purity graphite production from biogas, CAPEX approval to proceed with the company's commercial demonstration plant and offtake discussions.

Click here to view video
LBT Innovations (ASX:LBT) - intelligent automation for the lab
LBT Innovations (ASX:LBT) - intelligent automation for the lab

26 May 2020 - LBT Innovations Limited (ASX:LBT) Managing Director and CEO Brent Barnes talks about progress with the company's microbiology culture plate reading device APAS Independence, which uses artificial intelligence to read and interpret plates, additional analysis module development, sales pipeline and strategy.

Click here to view video
Novonix (ASX:NVX) - new manufacturing method for battery materials
Novonix (ASX:NVX) - new manufacturing method for battery materials

22 May 2020 - Novonix Limited (ASX:NVX) Managing Director Philip St Baker talks about the company's breakthrough dry particle microgranulation (DPMG) method for reducing waste in the manufacture of anode and cathode materials for lithium-ion batteries, restarting of operations in North America and outlook for 2H20.

Click here to view video
Elixinol Global (ASX:EXL) new focus, capital raising
Elixinol Global (ASX:EXL) new focus, capital raising

13 May 2020 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its strategy to create a global nutraceuticals brand, with a focus on higher margin, consumer branded products, new management team, capital raising and FY 20 outlook.

Click here to view video
Acorn Capital Investment Fund (ASX: ACQ) small cap specialist
Acorn Capital Investment Fund (ASX: ACQ) small cap specialist

06 May 2020 - Acorn Capital Investment Fund Ltd. (ASX: ACQ) Head of Research and Portfolio Manager for the Consumer Discretionary, Consumer Staples and Information Technology sectors, Robert Bruce talks about the listed investment company, the fund's composition and outlook for the next 6 months and longer term.

Click here to view video
Acorn Capital microcap and emerging company specialist
Acorn Capital microcap and emerging company specialist

01 May 2020 - Acorn Capital, Head of Portfolio Implementation and Portfolio manager (Healthcare and Biotechnology sectors) Paul Palumbo looks the microcap sector and the recent market sell off and discusses the outlook for next 6 months and longer term.

Click here to view video
BrainChip Holdings (ASX:BRN) neuromorphic computing
BrainChip Holdings (ASX:BRN) neuromorphic computing

28 Apr 2020 - BrainChip Holdings (ASX:BRN BrainChip Holdings (ASX:BRN) CEO Lou DiNardo talks about its Akida integrated circuit, its advantages in event-based convolutional (e-conv) networks, applications and its move to wafer production and first engineering samples by Q3 2020.

Click here to view video
Aus Tin Mining (ASX:ANW) farm-in agreement for Lachlan Fold Belt
Aus Tin Mining (ASX:ANW) farm-in agreement for Lachlan Fold Belt

27 Apr 2020 - Aus Tin Mining (ASX:ANW) CEO, Peter Williams talks farm-in agreement for exploration licences prospective for copper and gold in the Lachlan Fold Belt and proposal to divest its Granville Tin Mine.

Click here to view video
Kazia Therapeutics (ASX:KZA) glioblastoma Phase II trial results
Kazia Therapeutics (ASX:KZA) glioblastoma Phase II trial results

27 Apr 2020 - Kazia Therapeutics (ASX:KZA) CEO & MD, Dr. James Garner talks about its Phase II interim results for its glioblastoma drug candidate paxasilib, its pivotal GBM AGILE Phase II clinical study to commence 2H20 and value drivers as the company moves toward registration.

Click here to view video
Telix Pharmaceuticals (ASX:TLX) diagnostic and therapeutic biotech
Telix Pharmaceuticals (ASX:TLX) diagnostic and therapeutic biotech

24 Apr 2020 - Telix Pharmaceuticals (ASX:TLX), Chief Business Officer, David Cade talks about its prostate cancer imaging product, diagnostic and therapeutic products, partners and key priorities for 2020.

Click here to view video
Cyclopharm (ASX:CYC) submits FDA approval for Technegas
Cyclopharm (ASX:CYC) submits FDA approval for Technegas

06 Apr 2020 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its new drug application with the US FDA for Technegas and applications beyond pulmonary embolism in chronic chronic obstructive pulmonary ( COPD ) and asthma.

Click here to view video
Lithium Consolidated (ASX:LI3) portfolio update and drill program
Lithium Consolidated (ASX:LI3) portfolio update and drill program

26 Mar 2020 - Lithium Consolidated Mineral Exploration Limited (ASX:LI3) Managing Director Andrew Haythorpe provides an update on the company's new WA projects prospective for gold, nickel and base metals, board changes and plans to improve the company's prospects.

Click here to view video
BluGlass (ASX:BLG) non-renounceable rights issue
BluGlass (ASX:BLG) non-renounceable rights issue

31 Mar 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO,Giles Bourne, talks about the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, independent validation of its RPCVD technology and its response to COVID-19.

Click here to view video
Cynata Therapeutics (ASX:CYP) 1H20 results & outlook
Cynata Therapeutics (ASX:CYP) 1H20 results & outlook

31 Mar 2020 - Cynata Therapeutics Limited (ASX:CYP) Managing Director, Dr Ross MacDonald, talks 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform.

Click here to view video
XTEK (ASX:XTE) 1H20 results and outlook
XTEK (ASX:XTE) 1H20 results and outlook

30 Mar 2020 - XTEK Limited (ASX:XTE) Managing Director Philippe Odouard talks 1H20 results, the company's front-line products for the Australian Defence Force and police forces, US strategy and outlook.

Click here to view video
Cashwerkz (ASX:CWZ) 1H20 results & outlook
Cashwerkz (ASX:CWZ) 1H20 results & outlook

26 Mar 2020 - Cashwerkz Limited (ASX:CWZ) Executive Chairman John Nantes talks about the company's 1H20 results, new partners to the platform, outlook for the second half and impact of COVID-19.

Click here to view video
First Graphene (ASX:FGR) 1H20 results & outlook
First Graphene (ASX:FGR) 1H20 results & outlook

18 Mar 2020 - First Graphene Limited (ASX:FGR) Executive Director and CFO, Peter Youd, talks about the company's 1H20 results, progress with key customer trials and work at the Graphene Engineering & Innovation Centre (GEIC) in Manchester, UK.

Click here to view video
SUDA Pharmaceuticals (ASX:SUD) 1H20 results & outlook
SUDA Pharmaceuticals (ASX:SUD) 1H20 results & outlook

13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi's blockbuster insomnia drug Ambien and focus for 2020.

Click here to view video
Immutep (ASX:IMM) 1H20 results & outlook
Immutep (ASX:IMM) 1H20 results & outlook

11 Mar 2020 - Immutep Limited (ASX:IMM) CEO, Marc Voigt provides an update on the company's 1H20 results, including data from its clinical trials, collaborations with major pharma and outlook for the second half.

Click here to view video
Prospect Resources (ASX:PSC) - spodumene and petalite developer
Prospect Resources (ASX:PSC) - spodumene and petalite developer

10 Mar 2020 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack, provides an update on the company's key lithium petalite project in Zimbabwe.

Click here to view video
Opthea (ASX:OPT) combatting macular degeneration
Opthea (ASX:OPT) combatting macular degeneration

10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).

Click here to view video
Lithium Power International (ASX:LPI) secures environmental approval for Maricunga
Lithium Power International (ASX:LPI) secures environmental approval for Maricunga

09 Mar 2020 - Lithium Power International Limited (ASX:LPI) Managing Director and CEO Cristobal Garcia-Huidobro and Executive Director and CFO Andrew Phillips discuss the Environmental Approval for the company's Maricunga lithium brine project in Northern Chile, what this means for the project, and what's planned.

Click here to view video
Catapult (ASX:CAT) 1H20 results & outlook
Catapult (ASX:CAT) 1H20 results & outlook

03 Mar 2020 - Catapult Limited (ASX:CAT) CEO, Will Lopes discusses 1H20 results and outlook.

Click here to view video
InPayTech (ASX:IP1) 1H20 results & outlook
InPayTech (ASX:IP1) 1H20 results & outlook

02 Mar 2020 - Integrated Payment Technologies Limited (ASX:IP1) CEO, Dean Martin, discusses 1H20 results, customers numbers and take up for the company's ClickSuper and PayVu systems and integration with accounting platforms.

Click here to view video
Washington H. Soul Pattinson and Company Limited (ASX:SOL) stewardship and outlook
Washington H. Soul Pattinson and Company Limited (ASX:SOL) stewardship and outlook

28 Feb 2020 - Washington H. Soul Pattinson and Company Limited (ASX:SOL) Managing Director, Todd Barlow provides a portfolio update and talks about the approach to investment that has enabled the company to outperform over decades.

Click here to view video
NetLinkz (ASX:NET) agreement to monitor water quality in Sichuan Province
NetLinkz (ASX:NET) agreement to monitor water quality in Sichuan Province

27 Feb 2020 - NetLinkz Limited (ASX:NET) Executive Chairman and CEO, James Tsiolis talks about the significance of the company's agreement to provides its Virtual Secure Network to a World Bank-sponsored initiative to improve water sanitation services in selected areas of the Deyang Municipality of Sichuan Province.

Click here to view video
Ingenia Communities Group (ASX:INA) 1H20 results & outlook
Ingenia Communities Group (ASX:INA) 1H20 results & outlook

27 Feb 2020 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble, discusses 1H20 results, the company's portfolio and the demand for seniors accommodation.

Click here to view video
Renergen (ASX:RLT) natural gas and helium producer
Renergen (ASX:RLT) natural gas and helium producer

26 Feb 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO, Stefano Marani provides an update on recent drilling results at the company's Virginia Gas Project in South Africa, what's planned for this year and the potential to bring forward a second production well.

Click here to view video
Noxopharm (ASX:NOX) LuPIN trial in prostate cancer
Noxopharm (ASX:NOX) LuPIN trial in prostate cancer

25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.

Click here to view video
BluGlass (ASX:BLG) discusses laser diodes and business opportunities
BluGlass (ASX:BLG) discusses laser diodes and business opportunities

19 Feb 2020 - BluGlass Limited (ASX:BLG) Managing Director, Giles Bourne talks about the opportunities that laser diodes represent for the company, following the Photonics West Conference.

Click here to view video
Centuria Capital Group (ASX:CNI) 1H20 results & outlook
Centuria Capital Group (ASX:CNI) 1H20 results & outlook

13 Feb 2020 - Centuria Capital Group (ASX:CNI) Joint CEO, John McBain talks 1H20 results & outlook, including the contribution from recent acquisitions as group AUM now exceeds $7.3B.

Click here to view video
Mayur Resources (ASX:MRL) - PNG resource developer
Mayur Resources (ASX:MRL) - PNG resource developer

12 Feb 2020 - Mayur Resources Limited (ASX:MRL) Managing Director, Paul Mulder provides an update on the company's PNG projects, which span industrial minerals, power generation, coal, copper and gold.

Click here to view video
Aus Tin Mining (ASX:ANW) Taronga drill program
Aus Tin Mining (ASX:ANW) Taronga drill program

05 Feb 2020 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams, talks about proposed drilling at the company's Taronga tin project and the potential for an upside in tin grades.

Click here to view video
Centuria Industrial REIT (ASX:CIP) 1H20 results & outlook
Centuria Industrial REIT (ASX:CIP) 1H20 results & outlook

05 Feb 2020 - Centuria Industrial REIT (ASX:CIP) Fund Manager, Jesse Curtis talks 1H20 results, portfolio metrics and trends.

Click here to view video
Centuria Metropolitan REIT (ASX:CMA) 1H20 results & outlook
Centuria Metropolitan REIT (ASX:CMA) 1H20 results & outlook

05 Feb 2020 - Centuria Metropolitan REIT (ASX:CMA) Fund Manager, Grant Nichols talks 1H20 results, portfolio metrics and guidance.

Home

Search

Login

Report a bug